InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,221.42
(
-0.02%
)
US TECH 100
17,716.80
(
0.19%
)
Dow Jones
39,431.51
(
-0.21%
)
Brent Oil
83.24
(
0.03%
)
Bitcoin
62,548.91
(
-0.56%
)
Post# of 120
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Dean14

Send PM Follow Ignore
Followers 10
Posts 1729
Boards Moderated 0
Alias Born 06/14/2018

Dean14

Re: None

Tuesday, 12/10/2019 11:26:35 AM

Tuesday, December 10, 2019 11:26:35 AM

Post# of 120
One such company, Kannalife, Inc. has created a patented CBD-like molecule called KLS-13019, which researchers at the Lewis Katz School of Medicine at Temple University have proven to be five times safer and 1,000x more effective than CBD. Kannalife was awarded a grant from the National Institute on Drug Abuse (NIDA) to research the effects of KLS-13019 for chemotherapy-induced peripheral neuropathy (CIPN) and drug dependency and preliminary results from this research have been published in the Journal of Molecular Neuroscience.


https://www.tradersmagazine.com/departments/cannabis/cannabis-corner-fda-says-cbd-harmful-so-whats-next/
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up